Shareholding disclosure

Newron Pharmaceuticals SpA

Declared position

5.99%

Threshold

Crossed downwards

Timeline

Published

14.10.2016

Transaction

28.02.2014

Voting rights breakdown

Voting rights acquired0%
Voting rights sold5.99%
Below threshold0%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

TAGAC00099

Beneficial owner

Newron Pharmaceuticals SpA

Declared address

Newron Pharmaceuticals SpA, 20091 Bresso (MI)

28 February 2014 [remark: new disclosure law entered into force on 1 March 2013 and transitional period expired end of February 2014; the number of sale positions are up to date]. Entering into force of revised disclosure laws

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open